Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD) is a research paper published in eLife (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA251065
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: 320030_212583
National Institutes of Health
Grant: 5R01CA251065-02
A precision medicine approach to improve prediction of severe toxicity in fluorouracil chemotherapy
Fundação para a Ciência e a Tecnologia, I.P.
Grant: PTDC/CCI-BIO/29266/2017
Deep Drug Discovery and Deployment
Swiss National Science Foundation
Grant: 212583
The importance of regulatory genetic variation for the susceptibility to fluoropyrimidine-toxicity
Fields of Study
Keywords
Sustainable Development Goals